Intravenous delivery versus local injection

Category: Treatment methods · Editorial Review: Updated 20 October 2026 · 3 minute read

Route is part of the treatment

An intravenous infusion places material into the bloodstream. A local injection places it into or near a specific anatomical location. These are different interventions even when the same starting cells are used. The route affects distribution, exposure, procedural risks, and the proposed mechanism. Evidence for one route should not automatically be applied to another.

A systemic claim needs support

An IV is sometimes marketed as a way to treat multiple organs at once. That claim requires evidence that the product reaches relevant sites and produces meaningful benefits there. The convenience of administration does not demonstrate targeted repair. Ask which human outcomes support each proposed effect rather than accepting a broad list of conditions under one infusion.

Local does not mean simple

A local injection requires anatomical expertise and a clear indication. Depending on the site, imaging guidance or other safeguards may be relevant. Placing material close to a problem does not guarantee that it repairs the tissue. Ask what the procedure is intended to achieve and whether studies used the same technique and target location.

Compare the complete intervention

When discussing research, match the product, route, dose, condition, and follow-up. A study of a locally delivered product cannot establish that an IV version will have the same result. The clinician should explain why the chosen route fits the proposed biological effect and how route-specific risks will be managed.

Sources & further reading

• ISSCR — Guide to Stem Cell Treatments
• FDA — Information About Regenerative Medicine Therapies

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.